2006
DOI: 10.1016/j.yexcr.2005.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
45
0

Year Published

2006
2006
2024
2024

Publication Types

Select...
8
1
1

Relationship

3
7

Authors

Journals

citations
Cited by 34 publications
(49 citation statements)
references
References 32 publications
4
45
0
Order By: Relevance
“…Until the introduction of luteinizing hormone-releasing hormone agonist therapy, estrogen therapy was often used for hormonal manipulation of PCa. (34) Because estradiol treatment produces a selective decrease in RIZ1 expression, (35) it is interesting to investigate the RIZ1 expression in PCa tissues from patients who received preoperative hormone treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Until the introduction of luteinizing hormone-releasing hormone agonist therapy, estrogen therapy was often used for hormonal manipulation of PCa. (34) Because estradiol treatment produces a selective decrease in RIZ1 expression, (35) it is interesting to investigate the RIZ1 expression in PCa tissues from patients who received preoperative hormone treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Human PRDM2 (also known as RIZ1) is a strong tumor suppressor that induces G2/M cell cycle arrest and/or apoptosis in various tumor cells (6,9,10). Its PR domain can methylate histone H3 lysine 9 (H3K9) and is necessary in the repression of estrogen signaling genes (3,11).…”
Section: Introductionmentioning
confidence: 99%
“…2A) is E 2 -sensitive. 22 Analysis of RIZ gene produced equally interesting results. The captured promoter 2 specifically associated, in fact, with increased amounts (60-70%) of molecules from exons 9a and 10 (where alternative polyA addition occurs) after hormone challenge and, as opposite, a decreased recovery of the E 2 -insensitive promoter (promoter 1) could be monitored (Fig.…”
Section: Cellsmentioning
confidence: 97%